Literature DB >> 17690304

Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility.

Beatrice B Yaroslavskiy1, Allison C Sharrow, Alan Wells, Lisa J Robinson, Harry C Blair.   

Abstract

In skeletal remodeling, osteoclasts degrade bone, detach and move to new locations. Mechanical stretch and estrogen regulate osteoclast motility via nitric oxide (NO). We have found previously that NO stimulates guanylyl cyclase, activating the cGMP-dependent protein kinase 1 (PKG1), reversibly terminating osteoclast matrix degradation and attachment, and initiating motility. The PKG1 substrate vasodilator-stimulated protein (VASP), a membrane-attachment-related protein found in complexes with the integrin alphavbeta3 in adherent osteoclasts, was also required for motility. Here, we studied downstream mechanisms by which the NO-dependent pathway mediates osteoclast relocation. We found that NO-stimulated motility is dependent on activation of the Ca(2+)-activated proteinase mu-calpain. RNA interference (RNAi) showed that NO-dependent activation of mu-calpain also requires PKG1 and VASP. Inhibition of Src kinases, which are involved in the regulation of adhesion complexes, also abolished NO-stimulated calpain activity. Pharmacological inhibition and RNAi showed that calpain activation in this process is mediated by the inositol (1,4,5)-trisphosphate receptor 1 [Ins(1,4,5)P(3)R1] Ca(2+) channel. We conclude that NO-induced motility in osteoclasts requires regulated Ca(2+) release, which activates mu-calpain. This occurs via the Ins(1,4,5)P(3)R1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690304      PMCID: PMC2976040          DOI: 10.1242/jcs.004184

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  50 in total

1.  Intracellular calcium puffs in osteoclasts.

Authors:  W Radding; S E Jordan; R B Hester; H C Blair
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1.

Authors:  A Grey; Y Chen; I Paliwal; K Carlberg; K Insogna
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

3.  Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase.

Authors:  K E Armour; K J Armour; M E Gallagher; A Gödecke; M H Helfrich; D M Reid; S H Ralston
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

4.  Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway.

Authors:  A Glading; P Chang; D A Lauffenburger; A Wells
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).

Authors:  K J Armour; R J van 't Hof; K E Armour; A C Torbergsen; P Del Soldato; S H Ralston
Journal:  Arthritis Rheum       Date:  2001-09

Review 6.  Molecular events caused by mechanical stress in bone.

Authors:  S Nomura; T Takano-Yamamoto
Journal:  Matrix Biol       Date:  2000-05       Impact factor: 11.583

7.  Nitric oxide mediates 17beta-estradiol-stimulated human and rodent osteoblast proliferation and differentiation.

Authors:  M C O'Shaughnessy; J M Polak; F Afzal; M V Hukkanen; P Huang; I MacIntyre; L D Buttery
Journal:  Biochem Biophys Res Commun       Date:  2000-11-02       Impact factor: 3.575

8.  Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3. Studies in human platelets ans transfected Chinese hamster ovary cells.

Authors:  C L Yap; S C Hughan; S L Cranmer; W S Nesbitt; M M Rooney; S Giuliano; S Kulkarni; S M Dopheide; Y Yuan; H H Salem; S P Jackson
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility.

Authors:  A Sanjay; A Houghton; L Neff; E DiDomenico; C Bardelay; E Antoine; J Levy; J Gailit; D Bowtell; W C Horne; R Baron
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

10.  Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts.

Authors:  I Nakamura; L Lipfert; G A Rodan
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

View more
  11 in total

Review 1.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

2.  FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts.

Authors:  Lisa J Robinson; Irina Tourkova; Yujuan Wang; Allison C Sharrow; Michael S Landau; Beatrice B Yaroslavskiy; Li Sun; Mone Zaidi; Harry C Blair
Journal:  Biochem Biophys Res Commun       Date:  2010-02-19       Impact factor: 3.575

Review 3.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

4.  Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.

Authors:  Beatrice B Yaroslavskiy; Irina Turkova; Yujuan Wang; Lisa J Robinson; Harry C Blair
Journal:  Lab Invest       Date:  2010-06-21       Impact factor: 5.662

Review 5.  Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis.

Authors:  Robin Park; Jong Dae Ji
Journal:  Inflamm Res       Date:  2016-02-06       Impact factor: 4.575

6.  YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.

Authors:  Jin-Wen Wang; Chin-Bin Yeh; Shao-Jiun Chou; Kuo-Cheng Lu; Tzu-Hui Chu; Wei-Yu Chen; Jui-Lin Chien; Mao-Hsiung Yen; Tien-Hua Chen; Jia-Fwu Shyu
Journal:  J Bone Miner Metab       Date:  2017-10-05       Impact factor: 2.626

7.  Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.

Authors:  Lisa J Robinson; Beatrice B Yaroslavskiy; Reed D Griswold; Eva V Zadorozny; Lida Guo; Irina L Tourkova; Harry C Blair
Journal:  Exp Cell Res       Date:  2009-01-30       Impact factor: 3.905

8.  Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.

Authors:  Lisa J Robinson; Salvatore Mancarella; Duangrat Songsawad; Irina L Tourkova; John B Barnett; Donald L Gill; Jonathan Soboloff; Harry C Blair
Journal:  Lab Invest       Date:  2012-04-30       Impact factor: 5.662

9.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

10.  Suppression of arthritis-induced bone erosion by a CRAC channel antagonist.

Authors:  Harry C Blair; Jonathan Soboloff; Lisa J Robinson; Irina L Tourkova; Quitterie C Larrouture; Michelle R Witt; Ida Holaskova; Rosana Schafer; Meenal Elliott; Raphael Hirsch; John B Barnett
Journal:  RMD Open       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.